Tempus AI, Inc.’s Lock-Up Period Will End on December 11th (NASDAQ:TEM)

Tempus AI’s (NASDAQ:TEM) lock-up period will expire on Wednesday, December 11th. Tempus AI had issued 11,100,000 shares in its public offering on June 14th. The total size of the offering was $410,700,000 based on an initial share price of $37.00. After the end of Tempus AI’s lock-up period, company insiders and major shareholders will be able to sell their shares of the company.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on TEM. Stifel Nicolaus downgraded shares of Tempus AI from a “buy” rating to a “hold” rating and raised their price target for the stock from $45.00 to $65.00 in a research report on Monday, November 11th. Bank of America cut shares of Tempus AI from a “buy” rating to a “neutral” rating and raised their target price for the stock from $45.00 to $60.00 in a report on Wednesday, October 2nd. Loop Capital upped their target price on Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a report on Tuesday, October 15th. Finally, Piper Sandler reissued a “neutral” rating and issued a $70.00 price target (up previously from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. Three equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $54.22.

Tempus AI Price Performance

Shares of TEM stock opened at $53.16 on Friday. Tempus AI has a 12-month low of $22.89 and a 12-month high of $79.49. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The business has a 50 day simple moving average of $53.61.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. First Horizon Advisors Inc. bought a new position in shares of Tempus AI in the third quarter valued at approximately $30,000. Sandia Investment Management LP acquired a new stake in Tempus AI in the second quarter worth approximately $136,000. Vestor Capital LLC acquired a new position in shares of Tempus AI during the 3rd quarter valued at $153,000. Stifel Financial Corp bought a new stake in shares of Tempus AI in the 3rd quarter worth $218,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd bought a new stake in shares of Tempus AI in the 3rd quarter worth $258,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.